- Home
- JZ vs ONCO Comparison
JZ vs ONCO Comparison
Compare JZ & ONCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JZ
- ONCO
- Stock Information
- Founded
- JZ 2011
- ONCO 2018
- Country
- JZ China
- ONCO United States
- Employees
- JZ N/A
- ONCO N/A
- Industry
- JZ Other Consumer Services
- ONCO Biotechnology: Pharmaceutical Preparations
- Sector
- JZ Real Estate
- ONCO Health Care
- Exchange
- JZ Nasdaq
- ONCO Nasdaq
- Market Cap
- JZ 4.9M
- ONCO 4.3M
- IPO Year
- JZ 2022
- ONCO 2022
- Fundamental
- Price
- JZ $1.40
- ONCO $2.46
- Analyst Decision
- JZ
- ONCO
- Analyst Count
- JZ 0
- ONCO 0
- Target Price
- JZ N/A
- ONCO N/A
- AVG Volume (30 Days)
- JZ 3.7K
- ONCO 30.2K
- Earning Date
- JZ 10-16-2025
- ONCO 11-13-2025
- Dividend Yield
- JZ N/A
- ONCO N/A
- EPS Growth
- JZ N/A
- ONCO N/A
- EPS
- JZ N/A
- ONCO N/A
- Revenue
- JZ $34,090,704.00
- ONCO $1,223,751.00
- Revenue This Year
- JZ N/A
- ONCO N/A
- Revenue Next Year
- JZ N/A
- ONCO N/A
- P/E Ratio
- JZ N/A
- ONCO N/A
- Revenue Growth
- JZ N/A
- ONCO N/A
- 52 Week Low
- JZ $1.30
- ONCO $2.10
- 52 Week High
- JZ $14.60
- ONCO $179.35
- Technical
- Relative Strength Index (RSI)
- JZ 37.46
- ONCO 35.96
- Support Level
- JZ $1.38
- ONCO $2.67
- Resistance Level
- JZ $1.47
- ONCO $2.90
- Average True Range (ATR)
- JZ 0.04
- ONCO 0.25
- MACD
- JZ -0.01
- ONCO -0.08
- Stochastic Oscillator
- JZ 6.09
- ONCO 20.90
About JZ Jianzhi Education Technology Group Company Limited
Jianzhi Education Technology Group Co Ltd engages in developing educational content to fulfill the massive demand for high-quality, professional development training resources in China. The company and its subsidiaries VIE and VIEs generate subscription revenue through selling subscriptions to online learning platforms, higher education institutions, and other institutional customers under a B2B2C model mainly through the platform of Sentu Academy; offering subscriptions concerning educational content in mobile video packages directly to end users under a B2C model through the platforms such as Fish Learning or Light Class, etc. It has two operating segments: Educational content services and other services and IT-related solution services.
About ONCO Onconetix Inc.
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. It has a product named Entadfi an FDA-approved once-daily oral therapeutic for the treatment of benign prostatic hyperplasia, a disorder of the prostate, along with building additional assets in therapeutics, diagnostics, and clinician services for oncology.